Press Releases
Date Title and Summary View
May 18, 2001 ***** THE WALL STREET TRANSCRIPT ***** 100 Wall Street, New York, NY 10005 VOICE: (212) 952-7400 FAX: (212) 668-9842; (212) 668-9858 Copyright1999WAL STREET TRANSCRIPT L CORPORATION-AllRightsReserved Website: http:...
May 9, 2001 HOLLISTON, Mass., May 9 /PRNewswire/ -- Harvard Bioscience Inc. (Nasdaq: HBIO) and NextGen Sciences Ltd. (Huntingdon, Cambridgeshire, United Kingdom), today announced a collaborative research and development agreement. Harvard Bioscience focuses on developing tools to alleviate critical bottlenecks in the drug discovery proces...
May 3, 2001 HOLLISTON, Mass., May 3 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that David Green, President of Harvard Bioscience, will make a presentation at the Dain Rauscher Wessels Genomics & Life Sciences Conference to be held May 7th and 8th in New York City. The theme of the conference will be - Biot...
May 1, 2001 HOLLISTON, Mass., May 1 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the acquisition of Warner Instruments Corporation, a leader in innovative cell and tissue electro-physiology research products. Formed in 1988, Warner Instruments designs, manufactures, and markets a wide array of products for cell...
Apr 25, 2001 HOLLISTON, Mass., April 25 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today reported record revenues for the first quarter of 2001. Financial highlights for the three months ended March 31, 2001 were as follows: Revenues for the first quarter of 2001 grew 29% before unfavorable foreign exchange effects. Includin...
Apr 19, 2001 HOLLISTON, Mass., April 19 /PRNewswire/ --Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce results for the first quarter of 2001 after the market closes on Wednesday, April 25, 2001. At 2:00 p.m. Eastern Time on April 26, 2001, management will host a conference call to discuss the Company's quarterly results, along with ...
Apr 10, 2001 HOLLISTON, Mass., April 10 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today reported that the United States District Court, District of Massachusetts has denied Harvard University's request for a preliminary injunction prohibiting Harvard Bioscience, Inc. from using the name "Harvard." The Court did issue an order that directs H...
Mar 28, 2001 HOLLISTON, Mass., March 28 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that David Green, President of Harvard Bioscience, will be a featured speaker at the Thomas Weisel Partners Healthcare Conference 2001 to be held April 2nd and 3rd in San Francisco, California. The theme of the conference will b...
Mar 19, 2001 HOLLISTON, Mass., March 19 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the introduction of MitoScan® toxicity screening assays, which offer rapid, convenient alternatives to cellular assays. (Photo: http://www.newscom.com/cgi-bin/prnh/20010319/NEM031) ...
Feb 27, 2001 HOLLISTON, Mass., Feb. 27 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the introduction of ScanTox™, a drug safety evaluation tool that provides a more sensitive means of lead optimization than currently available, as well as an in vitro alternative to the much criticized Drai...
FirstPrevious ...
30
NextLast
= add release to Briefcase